Health Catalyst

Health Catalyst Equity

The The Equity of Health Catalyst (HCAT) as of Oct 10, 2026 is 245.78 M USD. In the previous year, The Equity was 365.21 M USD — a change of -32.70% (lower).

Equity

245.78 MUSD

YoY

-32.70%

Last updated:

In 2025, Health Catalyst's equity was 245.78 M USD, a -32.70% increase from the 365.21 M USD equity in the previous year.

The Health Catalyst Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
-374.77 M USD
Jan 1, 2019
200.64 M USD
Jan 1, 2020
276.10 M USD
Jan 1, 2021
522.10 M USD
Jan 1, 2022
425.01 M USD
Jan 1, 2023
366.92 M USD
Jan 1, 2024
365.21 M USD
Jan 1, 2025
245.78 M USD
The Health Catalyst Equity history
YEAREquityYoY
245.78 MUSD-32.70%
365.21 MUSD-0.47%
366.92 MUSD-13.67%
425.01 MUSD-18.60%
522.10 MUSD+89.10%
276.10 MUSD+37.61%
200.64 MUSD-153.54%
-374.77 MUSD+44.43%
-259.48 MUSD—
Access this data via the Eulerpool API

Health Catalyst Stock analysis

What does Health Catalyst do? Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years. Health Catalyst is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Health Catalyst's Equity

Health Catalyst's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Health Catalyst's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Health Catalyst's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Health Catalyst's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Health Catalyst’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Health Catalyst stock

The Equity of Health Catalyst is 245.78 M USD in 2025.

The Equity of Health Catalyst changed from 365.21 M USD to 245.78 M USD, representing a -32.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Health Catalyst since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Health Catalyst historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Health Catalyst

All Key Metrics — Health Catalyst